Basic Information
| RNALocate ID: | RLID:11004327 |
| RNA Symbol: | hsa-miR-1251-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-1251 |
| RNA ID: | miRBase:MIMAT0005903 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID-D:11001700 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
| RLID-D:11004170 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-1251-5p | Prostate cancer | MNDR-E-MI-06595 |
| MNDR | hsa-miR-1251-5p | Gastric cancer | MNDR-E-MI-06596 |
| MNDR | hsa-miR-1251-5p | Alzheimer disease | MNDR-E-MI-06597 |
| MNDR | hsa-miR-1251-5p | Cardiovascular disease | MNDR-E-MI-06598 |
| MNDR | hsa-miR-1251-5p | Lung cancer | MNDR-E-MI-06599 |
| MNDR | hsa-miR-1251-5p | Parkinson disease | MNDR-E-MI-06600 |
| MNDR | hsa-miR-1251-5p | Pancreatic cancer | MNDR-E-MI-06601 |
| MNDR | hsa-miR-1251-5p | Colon cancer | MNDR-E-MI-06602 |
| MNDR | hsa-miR-1251-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-06603 |
| MNDR | hsa-miR-1251-5p | Ovarian cancer | MNDR-E-MI-06604 |
| MNDR | hsa-miR-1251-5p | Prostate adenocarcinoma | MNDR-E-MI-06605 |
| MNDR | hsa-miR-1251-5p | Glioblastoma | MNDR-E-MI-06606 |
| MNDR | hsa-miR-1251-5p | Thyroid carcinoma | MNDR-E-MI-06607 |
| MNDR | hsa-miR-1251-5p | Pancreatic adenocarcinoma | MNDR-E-MI-06608 |
| MNDR | hsa-miR-1251-5p | Carcinoma renal cell | MNDR-E-MI-06609 |
| MNDR | hsa-miR-1251-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-06610 |
| MNDR | hsa-miR-1251-5p | Renal clear cell carcinoma | MNDR-E-MI-06611 |
| MNDR | hsa-miR-1251-5p | Cholangiocarcinoma | MNDR-E-MI-06612 |
| MNDR | hsa-miR-1251-5p | Testicular germ cell cancer | MNDR-E-MI-06613 |
| MNDR | hsa-miR-1251-5p | T acute lymphoblastic leukemia | MNDR-E-MI-06614 |
| MNDR | hsa-miR-1251-5p | Acute t cell leukemia | MNDR-E-MI-06615 |
| MNDR | hsa-miR-1251-5p | Liver hepatocellular carcinoma | MNDR-E-MI-06616 |
| MNDR | hsa-miR-1251-5p | Colorectal cancer | MNDR-E-MI-06617 |
| MNDR | hsa-miR-1251-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-06618 |
TOP